Treatment for shoulder pain after stroke
Official title: Quantifying and Treating Myofascial Dysfunction in Post Stroke Shoulder Pain
Run by Johns Hopkins University · NCT06718413 · Data updated 2026-11-12
This study is testing whether hyaluronidase injections can help reduce shoulder pain in stroke survivors and improve their movement and quality of life.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 68 (estimated) |
| Sponsor | Johns Hopkins University Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Status | Recruiting |
| Started | March 28, 2025 |
| Main results expected | August 31, 2027 |
| Study ends | August 31, 2028 |
| Registry record updated | October 14, 2026 |
| Trial ID | NCT06718413 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who have experienced hemiparesis from a stroke and exhibit specific shoulder mobility issues.
✕Probably not a fit
Patients with other neurological conditions or significant cognitive dysfunction may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to investigate the effectiveness of hyaluronidase injections in reducing shoulder pain associated with post-stroke myofascial dysfunction. It will utilize T1rho MRI and ultrasound shear strain mapping to quantify changes in muscle function and pain levels before and after treatment. The study will compare the outcomes of patients receiving hyaluronidase versus a placebo, focusing on pain reduction, range of motion, and overall quality of life. The trial seeks to clarify the role of hyaluronic acid accumulation in shoulder pain post-stroke.
Why it matters
Potential benefit: If successful, this treatment could significantly alleviate shoulder pain and improve recovery outcomes for stroke patients.
How similar studies have gone: While the approach of using hyaluronidase for myofascial dysfunction is novel, similar studies have shown promise in treating pain through targeted interventions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * age ≥18 years; * hemiparesis from an ischemic or hemorrhagic stroke; * time since cerebral injury 3-180 months prior; * show a difference of more than 10 degrees of passive ER-ROM between non-paretic and paretic shoulders with or without pain * ability to give informed consent and HIPAA authorization, and comply with study protocols; Exclusion Criteria: * treatment of spasticity with Botulinum toxin or intrathecal baclofen within the past three months, phenol injections within the past 12 months, or ongoing adjustment of anti-spastic medications; * other neurologic condition that may affect motor response (e.g., Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), MS); * clinically significant cognitive dysfunction with score \<19 on Folstein's Mini Mental Status Examination or positive depression screening on the Patient Health Questionnaire (PHQ)-9; * pregnancy; * known hypersensitivity to hyaluronidase; * standard contraindications for MRI; * have non-musculoskeletal PSSP such as only central pain or chronic regional pain syndrome (CRPS) * any condition that will preclude the patient from completing the protocol as determined by the PI.
Where it's running
-
Johns Hopkins University
Baltimore, Maryland, United States Recruiting
Study contacts
- Principal investigator: Ning Cao, MD — Johns Hopkins University
- Study coordinator: Ning Cao, MD
- Email: ncao2@jhmi.edu
- Phone: 718-801-0026
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Web-based therapy using action observation and mirror therapy for arm weakness after stroke
This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
Dual-task balance training plus computer-based cognitive training after stroke
In adults who recently had a stroke, the study tests whether adding computerized cognitive exercises to balance training improves balance and other recovery outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.